Faiz Gani1, Fabian M Johnston1, Howard Nelson-Williams1, Marcelo Cerullo1, Mary E Dillhoff2, Carl R Schmidt2, Timothy M Pawlik3,4. 1. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 2. Department of Surgery, Wexner Medical Center at The Ohio State University, Columbus, OH, USA. 3. Department of Surgery, Wexner Medical Center at The Ohio State University, Columbus, OH, USA. tim.pawlik@osumc.edu. 4. Department of Surgery, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, Wexner Medical Center at The Ohio State University, 395 W. 12th Avenue, Suite 670, Columbus, OH, 43210, USA. tim.pawlik@osumc.edu.
Abstract
BACKGROUND: Data evaluating the financial implications of volume-based referral are lacking. This study sought to compare in-hospital costs for pancreatic surgery by annual hospital volume. METHODS: Eleven thousand and eighty-one patients aged ≥18 years undergoing an elective pancreatic resection for cancer were identified using the Nationwide Inpatient Sample 2002-2011. Multivariable regression analysis was performed to compare length-of-stay (LOS), postoperative morbidity and mortality, failure-to-rescue (FTR), and inpatient costs by annual hospital volume group. RESULTS: Patients undergoing surgery at high-volume hospitals (HVH) demonstrated 23% lower odds (odds ratio [OR] = 0.77, 95% confidence interval [95%CI] 0.63-0.95) of developing a postoperative complication, 59% lower odds of experiencing an LOS > 14 days (OR = 0.41, 95%CI 0.34-0.50), 51% lower odds of postoperative mortality (OR = 0.49, 95%CI 0.34-0.71), and 47% lower odds of FTR (OR = 0.53, 95%CI 0.37-0.76; all p<0.05). The overall mean in-hospital cost was $39,012 (SD = $15,214) with minimal differences observed across hospital volume groups. Rather, postoperative complications (no complication vs. complication $26,686 [SD = $5762] vs. $44,633 [SD = $11,637]) and FTR (rescue vs. FTR $42,413 [SD = $8481] vs. $69,546 [SD = $13,131]) were determinant of higher in-hospital costs. While this pattern was observed at all hospital volume groups, costs varied minimally between hospital volume groups after this stratification. CONCLUSIONS: Annual hospital surgical volume was not associated with in-hospital costs among patients undergoing pancreatic surgery.
BACKGROUND: Data evaluating the financial implications of volume-based referral are lacking. This study sought to compare in-hospital costs for pancreatic surgery by annual hospital volume. METHODS: Eleven thousand and eighty-one patients aged ≥18 years undergoing an elective pancreatic resection for cancer were identified using the Nationwide Inpatient Sample 2002-2011. Multivariable regression analysis was performed to compare length-of-stay (LOS), postoperative morbidity and mortality, failure-to-rescue (FTR), and inpatient costs by annual hospital volume group. RESULTS:Patients undergoing surgery at high-volume hospitals (HVH) demonstrated 23% lower odds (odds ratio [OR] = 0.77, 95% confidence interval [95%CI] 0.63-0.95) of developing a postoperative complication, 59% lower odds of experiencing an LOS > 14 days (OR = 0.41, 95%CI 0.34-0.50), 51% lower odds of postoperative mortality (OR = 0.49, 95%CI 0.34-0.71), and 47% lower odds of FTR (OR = 0.53, 95%CI 0.37-0.76; all p<0.05). The overall mean in-hospital cost was $39,012 (SD = $15,214) with minimal differences observed across hospital volume groups. Rather, postoperative complications (no complication vs. complication $26,686 [SD = $5762] vs. $44,633 [SD = $11,637]) and FTR (rescue vs. FTR $42,413 [SD = $8481] vs. $69,546 [SD = $13,131]) were determinant of higher in-hospital costs. While this pattern was observed at all hospital volume groups, costs varied minimally between hospital volume groups after this stratification. CONCLUSIONS: Annual hospital surgical volume was not associated with in-hospital costs among patients undergoing pancreatic surgery.
Authors: John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg Journal: N Engl J Med Date: 2002-04-11 Impact factor: 91.245
Authors: Deborah Schrag; Katherine S Panageas; Elyn Riedel; Laura D Cramer; Jose G Guillem; Peter B Bach; Colin B Begg Journal: Ann Surg Date: 2002-11 Impact factor: 12.969
Authors: William S Knechtle; Sebastian D Perez; Rachel L Medbery; Bryce D Gartland; Patrick S Sullivan; Stuart J Knechtle; David A Kooby; Shishir K Maithel; Juan M Sarmiento; Virginia O Shaffer; Jahnavi K Srinivasan; Charles A Staley; John F Sweeney Journal: Ann Surg Date: 2015-08 Impact factor: 12.969
Authors: Ibrahim Nassour; Sam C Wang; Alana Christie; Mathew M Augustine; Matthew R Porembka; Adam C Yopp; Michael A Choti; John C Mansour; Xian-Jin Xie; Patricio M Polanco; Rebecca M Minter Journal: Ann Surg Date: 2018-07 Impact factor: 12.969
Authors: Sunil Eappen; Bennett H Lane; Barry Rosenberg; Stuart A Lipsitz; David Sadoff; Dave Matheson; William R Berry; Mark Lester; Atul A Gawande Journal: JAMA Date: 2013-04-17 Impact factor: 56.272
Authors: Cheryl K Zogg; Taylor D Ottesen; Kareem J Kebaish; Anoop Galivanche; Shilpa Murthy; Navin R Changoor; Donald L Zogg; Timothy M Pawlik; Adil H Haider Journal: J Gastrointest Surg Date: 2018-06-26 Impact factor: 3.452
Authors: Eliza W Beal; Rittal Mehta; J Madison Hyer; Anghela Paredes; Katiuscha Merath; Mary E Dillhoff; Jordan Cloyd; Aslam Ejaz; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2019-02-27 Impact factor: 3.452
Authors: Nadia N Khan; Tennille Lewin; Amy Hatton; Charles Pilgrim; Liane Ioannou; Luc Te Marvelde; John Zalcberg; Sue Evans Journal: Am J Cancer Res Date: 2022-02-15 Impact factor: 6.166